Additionally, only very few participants had additional Tau imaging and/or 18F‐Fluorodeoxyglucose‐PET, and we could not compare the agreement of CSF pTau and tTau with molecular imaging markers of the “T” and the “N” categories of the ATN classification. Here, MAPT is linked to oculocutaneous albinism type 1.